Amphotericin B liposomal
Kathryn Dzintars, Pharm.D., BCPS
,
Paul A. Pham, Pharm.D.
Pediatric Dosing Author:
Alice Jenh Hsu, PharmD, BCPS, AQ-ID
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Aspergillosis
(in patients refractory to or intolerant of amphotericin B deoxycholate)
Candidiasis
(in patients refractory to or intolerant of amphotericin B deoxycholate)
Cryptococcosis
(in patients refractory to or intolerant of amphotericin B deoxycholate)
Empiric therapy for presumed fungal infection in patients with febrile neutropenia
Visceral leishmaniasis
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Zygomycetes
and other invasive molds
Coccidioidomycosis
Histoplasmosis
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved